A. E. Eskazan Et Al. , "FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE," 19th Congress of the European-Hematology-Association , vol.99, Milan, Italy, pp.330-331, 2014
Eskazan, A. E. Et Al. 2014. FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE. 19th Congress of the European-Hematology-Association , (Milan, Italy), 330-331.
Eskazan, A. E., Baslar, Z., Ayer, M., Kantarcioglu, B., Arica, D., Demirel, N., ... Aydin, D.(2014). FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE . 19th Congress of the European-Hematology-Association (pp.330-331). Milan, Italy
Eskazan, A. Et Al. "FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE," 19th Congress of the European-Hematology-Association, Milan, Italy, 2014
Eskazan, A. E. Et Al. "FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE." 19th Congress of the European-Hematology-Association , Milan, Italy, pp.330-331, 2014
Eskazan, A. E. Et Al. (2014) . "FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE." 19th Congress of the European-Hematology-Association , Milan, Italy, pp.330-331.
@conferencepaper{conferencepaper, author={A. E. Eskazan Et Al. }, title={FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE}, congress name={19th Congress of the European-Hematology-Association}, city={Milan}, country={Italy}, year={2014}, pages={330-331} }